FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/066800 [Registered on: 06/05/2024] Trial Registered Prospectively
Last Modified On: 03/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   To study the effect of Duralabhadi Churna in vatik kasa(Dry cough)in children 
Scientific Title of Study   A Single Arm Clinical Study To Evaluate The Efficacy Of Duralabhadi Churna In The Management Of Vatik Kasa In Children. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rukhsana Sheikh 
Designation  MD Scholar 
Affiliation  Dr.D.Y.Patil College Of Ayurveda and Research Centre Pimpri Pune 
Address  OPD No.1 and IPD Kaumarbhritya Department,Dr.D.Y.Patil College Of Ayurveda and Research Centre,Sant Tukaram Nagar, Pimpri, Pune

Pune
MAHARASHTRA
411018
India 
Phone  8269347231  
Fax    
Email  rukhsanasheikh17@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mosim Gafur Momin 
Designation  Associate Professor 
Affiliation  Dr.D.Y.Patil College Of Ayurveda and Research Centre,Sant Tukaram Nagar, Pimpri, Pune  
Address  OPD No.1 and IPD Kaumarbhritya Department,Dr.D.Y.Patil College Of Ayurveda and Research Centre,Sant Tukaram Nagar, Pimpri, Pune

Pune
MAHARASHTRA
411018
India 
Phone  7350751503  
Fax    
Email  dr.mosim2010@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Rukhsana Sheikh 
Designation  MD Scholar 
Affiliation  Dr.D.Y.Patil College Of Ayurveda and Research Centre Pimpri Pune 
Address  OPD No.1 and IPD Kaumarbhritya Department,Dr.D.Y.Patil College Of Ayurveda and Research Centre,Sant Tukaram Nagar, Pimpri, Pune

Pune
MAHARASHTRA
411018
India 
Phone  08269347231  
Fax    
Email  rukhsanasheikh17@gmail.com  
 
Source of Monetary or Material Support  
Dr.D.Y.Patil College Of Ayurveda and Research Centre,Sant Tukaram Nagar, Pimpri, Pune, Maharashtra 411018 
 
Primary Sponsor  
Name  Dr Rukhsana Sheikh 
Address  OPD No.1 and IPD Kaumarbhritya Department,Dr.D.Y.Patil College Of Ayurveda and Research Centre,Sant Tukaram Nagar, Pimpri, Pune, Maharashtra 411018 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rukhsana Sheikh  Dr.D.Y.Patil College Of Ayurveda and Research Centre Pimpri Pune 18  OPD No.1 and IPD Kaumarbhritya Department,Dr.D.Y.Patil College Of Ayurveda and Research Centre,Sant Tukaram Nagar, Pimpri, Pune
Pune
MAHARASHTRA 
08269347231

rukhsanasheikh17@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
DR DYPCA AND RC INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:R05||Cough. Ayurveda Condition: KASAH, (2) ICD-10 Condition:J00-J99||Diseases of the respiratory system. Ayurveda Condition: KASAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Duralabhadi Curna, Reference: Yoga Ratnakara chapter-Balrogadhikar Shloka no.1 pg no.445, Route: Oral, Dosage Form: Churna/ Powder, Dose: 6(g), Frequency: tds, Bhaishajya Kal: Muhurmuhu, Duration: 5 Days, anupAna/sahapAna: Yes(details: -Madhu), Additional Information: -Drug dose will be given by according to age
 
Inclusion Criteria  
Age From  1.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  1)The patients having minimum 2 symptoms of Vatik Kasa are as follows-
1.The frequency of Kasa vega (Dry Cough)
2.Udarparshwa Shula (chest pain)
3.Swarbheda (Hoarseness of Voice)
4.Shukpurna Galasyata (Feeling Of Thorn Pricking in the Throat)
2) Patients between the ages of 1 year and 12 year.
3) The patients whose parents are ready to participate in the clinical trial by giving informed written consent.
 
 
ExclusionCriteria 
Details  1)Patients of other types of kasa (pittaj, kaphaj,
kshayaj, kshataj)
2)Patients having life threatening illness and who is bed ridden.
3)Patients having any congenital respiratory and
GIT abnormality.
4)Patients who require surgical management. 5)Patients having concomitant other systemic disorders like T.B., Bronchiolitis, Asthma, Pneumonia, Bronchiectasis, Lung abscess, Foreign body, pertussis etc.
6)Patient having complaint of fever or recent history of fever .
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement in swarabheda & kasa vega after taking

Duralabhadi Churna in the management of Vatik Kasa.
 
5 Days study with followup on 3rd and 5th day 
 
Secondary Outcome  
Outcome  TimePoints 
To study the Adverse effect of Duralabhadi Churna, if any  5 Days study with followup on 3rd and 5th day (0,3,5 Days) 
 
Target Sample Size   Total Sample Size="45"
Sample Size from India="45" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   15/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This is a single arm clinical study in which the medicine Duralabhadi Churna will be given to 45 patients who have sign and symptoms of Vatik Kasa. The age group taken the study trial will be between 1 and 12 years old. Duralabhadi Churna with Madhu will be given for 5 days or three a day. Dose will be calculated by age formula. Follow-up will be done on the 3rd and 5th days of the case study, for a total duration of 5 days. The final conclusion will be drawn using statistical methods.

 
Close